iShares U.S. Pharmaceuticals ETF (IHE) Performance

NYSE Arca: IHETotal returns, calendar years, drawdowns and risk since 2006.

IHE total return

Distributions reinvested · as of Oct 23, 2026
YTD
+21.9%
since Dec 31, 2025
1 year
+39.2%
total return
5 years
+12.4%
a year
10 years
+9.6%
a year
Since first price
+10.9%
a year since 2006

IHE trailing returns vs SPY, QQQ, AGG

IHE trailing returns
PeriodIHE total returnPrice onlyS&P 500 (SPY)Nasdaq-100 (QQQ)U.S. bonds (AGG)
1 month+1.2%+1.2%−1.0%−5.0%+0.9%
3 months+0.8%+0.5%+3.2%+1.9%−0.4%
6 months+18.7%+18.0%+7.8%+8.4%−1.5%
YTD+21.9%+20.8%+12.3%+15.1%−1.0%
1 year+39.2%+37.0%+14.4%+15.9%−1.1%
3 years+87.2%+23.3%/yr+78.5%+87.4%+23.3%/yr+101.4%+26.3%/yr+16.6%+5.2%/yr
5 years+79.2%+12.4%/yr+64.7%+79.3%+12.4%/yr+94.0%+14.2%/yr−0.8%−0.2%/yr
10 years+149.9%+9.6%/yr+114.5%+315.9%+15.3%/yr+538.9%+20.4%/yr+14.0%+1.3%/yr
15 years+456.9%+12.1%/yr+344.3%+696.0%+14.8%/yr+1,299.3%+19.2%/yr+32.2%+1.9%/yr
20 years+660.7%+10.7%/yr+466.3%+696.9%+10.9%/yr+1,839.9%+16.0%/yr+79.6%+3.0%/yr
Since inceptionMay 5, 2006+727.0%+10.9%/yr+513.1%———

Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.

Growth of $10,000: IHE vs SPY

IHES&P 500 (SPY)

From May 5, 2006: IHE grew to $82,703, SPY to $83,394.

Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.

IHE returns by calendar year

IHESPY

15 of 19 full years positive. Best 2013 (+40.6%), worst 2008 (−14.9%). 2026 is year to date.

IHE annual returns table

IHE calendar-year returns
YearIHELargest dropSPYQQQAGG
2026YTD+21.9%−9.7%+12.3%+15.1%−1.0%
2025+31.7%−15.9%+17.7%+20.8%+7.2%
2024+8.1%−9.8%+24.9%+25.6%+1.3%
2023+1.1%−12.5%+26.2%+54.9%+5.7%
2022−4.9%−16.0%−18.2%−32.6%−13.0%
2021+13.1%−7.8%+28.7%+27.4%−1.8%
2020+13.7%−29.2%+18.3%+48.6%+7.5%
2019+15.5%−12.0%+31.2%+39.0%+8.5%
2018−7.8%−21.8%−4.6%−0.1%+0.1%
2017+10.6%−7.2%+21.7%+32.7%+3.6%
2016−11.7%−17.9%+12.0%+7.1%+2.4%
2015+8.8%−22.1%+1.2%+9.4%+0.5%
2014+29.9%−10.4%+13.5%+19.2%+6.0%
2013+40.6%−5.3%+32.3%+36.6%−2.0%
2012+13.4%−10.4%+16.0%+18.1%+3.8%
2011+20.9%−16.9%+1.9%+3.4%+7.7%
2010+12.7%−11.3%+15.1%+19.9%+6.4%
2009+30.1%−22.2%+26.4%+54.7%+3.0%
2008−14.9%−32.8%−36.8%−41.7%+7.9%
2007+2.4%−11.0%+5.1%+19.0%+6.6%

Largest drop = deepest fall from a high within that calendar year.

Calendar-year return vs largest drop within the year

Calendar-year returnLargest drop within the year

Most years include a sizable fall at some point even when the year ends higher.

IHE largest drawdowns

Now 5.0% below the high
IHE largest drawdowns
PeakDeclineBottomRecoveredFallUnderwater
May 22, 2007−38.2%Mar 5, 2009Dec 14, 20091.8 years2.6 years
Jul 16, 2015−32.2%Mar 23, 2020Oct 9, 20204.7 years5.2 years
Jul 7, 2011−16.9%Aug 8, 2011Dec 20, 201132 days5 months
Apr 7, 2022−16.0%Oct 10, 2022Feb 5, 20246 months1.8 years
Mar 3, 2025−15.9%Apr 10, 2025Sep 30, 202538 days7 months
Mar 23, 2010−11.3%Jun 8, 2010Sep 20, 20103 months6 months

Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.

IHE risk statistics

IHE risk statistics
Statistic3 years5 years10 yearsSince 2006
Annualized return+21.4%+12.4%+8.9%+11.0%
Volatility (annualized)15.3%15.3%15.5%15.6%
Sharpe ratio1.060.610.480.67
Sortino ratio2.001.010.751.04
Best month+12.4%+12.4%+13.2%+13.2%
Worst month−5.6%−7.6%−10.4%−13.0%
Best 12 months+57.3%+57.3%+57.3%+57.3%
Worst 12 months−2.0%−9.9%−16.9%−23.3%
Positive months72%62%60%62%
Beta vs S&P 5000.410.470.66—
Correlation with S&P 5000.330.480.65—

From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.

IHE rolling returns

IHE rolling returns
Holding periodPeriodsWorstMedianBestPositive
1-year234−23.3%+11.0%+57.3%74%
3-year (a year)210−4.3%+7.7%+31.6%92%
5-year (a year)186−3.5%+9.6%+29.9%97%
10-year (a year)126+2.4%+11.2%+16.6%100%

Every holding period starting at a month-end since 2006. Returns for 3 years and longer are annualized.

IHE performance overview

iShares U.S. Pharmaceuticals ETF (IHE) returned +39.2% over the past year and +9.6% a year over ten years, with distributions reinvested. Since its first recorded price in 2006 it has returned +10.9% a year, turning $10,000 into about $82,703. Over the same year S&P 500 (SPY) returned +14.4%.

The deepest decline was −38.2%, from May 22, 2007 to Mar 5, 2009, and it took 9 months to get back to the old high. IHE finished 15 of its 19 full calendar years with a gain; the best year was 2013 (+40.6%) and the worst 2008 (−14.9%). Volatility has been 15.6% a year.

Related: IHE chart, IHE holdings, IHE dividends, IHE valuation. See the IHE overview for the latest quote and fund facts.

IHE performance FAQ

What is the IHE return over the past year?

IHE returned +39.2% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 37.0%.

What is the average annual return of IHE?

IHE has returned +12.4% a year over 5 years, +9.6% a year over 10 years, +10.9% a year since May 5, 2006 (total return, distributions reinvested).

How much would $10,000 invested in IHE be worth?

$10,000 invested in IHE at its first recorded close on May 5, 2006 would be worth about $82,703 on October 23, 2026 with distributions reinvested.

What was the worst year for IHE?

The worst calendar year was 2008, with a total return of −14.9%. The best was 2013 at +40.6%.

What is the biggest drawdown of IHE?

The largest peak-to-trough decline was −38.2% between May 22, 2007 and March 5, 2009. It recovered to the old high on December 14, 2009, 9 months after the bottom.

How volatile is IHE?

Over the past 3 years IHE had an annualized volatility of 15.3% and a Sharpe ratio of 1.06 (excess return over 1–3 month T-bills per unit of risk).